Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
127 hedge funds and large institutions have $596M invested in Pactiv Evergreen Inc. Common stock in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 11 closing their positions.
1,800% more call options, than puts
Call options by funds: $931K | Put options by funds: $49K
155% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 11
85% more capital invested
Capital invested by funds: $322M → $596M (+$274M)
24% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 38
14% more funds holding
Funds holding: 111 → 127 (+16)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$43.1M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$4.98M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.24M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.05M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ER
EVR Research
Richmond,
Virginia
|
-$11.8M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$6.5M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.38M |
| 4 |
JCA
Jade Capital Advisors
Essex Fells,
New Jersey
|
-$1.58M |
| 5 |
CM
CastleKnight Management
New York
|
-$1.43M |
PTVE Hedge Fund Activity: Q4 2023 in Review
127 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q4 2023, worth a combined $596M — up 85% from $322M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new PTVE positions and 11 closed out — a net gain of 17 holders — while 47 added to existing stakes and 38 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $43.1M. The largest seller was EVR Research, cutting an estimated $11.8M.
- 127 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q4 2023, up from 111 in Q3 2023.
- Funds reported $596M of Pactiv Evergreen Inc. Common stock stock for Q4 2023, up 85% quarter-over-quarter.
- 28 funds opened new Pactiv Evergreen Inc. Common stock positions in Q4 2023 and 11 closed out, a net change of +17 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q4 2023 was Morgan Stanley, an estimated $43.1M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q4 2023 was EVR Research, an estimated $11.8M sold.
Based on aggregated 13F filings for Q4 2023.